XM does not provide services to residents of the United States of America.

India's Manappuram Finance tanks to over 4-yr low on downgrades after cenbank bars unit



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>India's Manappuram Finance tanks to over 4-yr low on downgrades after cenbank bars unit</title></head><body>

Oct 18 (Reuters) -Manappuram Finance's MNFL.NS shares slumped 16% on Friday, their biggest decline since March 2020, after the Indian central bank's lending restrictions on the company's unit triggered rating downgrades due toconcerns over a potential hit to earnings.

The non-bank lender's shares fell as much as 18% to 145.42 rupees, their lowest in 10 months, before paring some losses.

The Reserve Bank of India (RBI) on Thursday barred four non-bank finance companies (NBFCs), including Manappuram's unit Asirvad Micro Finance, from sanctioning and disbursing loans due to "usurious" pricing and for charging a significant mark-up over their funding costs.

Asirvad contributes about 27% to Manappuram's consolidated assets under management (AUM), according to two brokerage estimates.

Brokerages including Morgan Stanley, Jefferies and Motilal Oswal downgraded their ratings on the stock and cut target prices after the RBI's move.

Manappuram, could see a rise in funding costs and may have to support Asirvad with funding, Morgan Stanley said in a note, downgrading the stock to "equal-weight" from "over-weight". It reduced its target price by 35% to 170 rupees.

"It (Manappuram)could also face loan growth moderation, tighter credit practices, and higher provisioning to give comfort to all stakeholders," Morgan Stanley analysts said.

Jefferies downgraded the stock to "hold" from "buy" and cut its target price by 38% to 167 rupees, saying a potential rise in defaults at Asirvad could hurt Manappuram's profit.

Asirvad is expected to see a 25% decline in AUM in 2025, Motilal Oswal said, downgrading the stock to "neutral" from "buy".

Manappuram shares are down 12% so far this year, compared to a 32% rise in rival Muthoot Finance MUTT.NS.




Reporting by Dimpal Gulwani and Siddhi Nayak; Editing by Sonia Cheema

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.